TELA Bio (TELA) EBT (2018 - 2026)

TELA Bio's EBT history runs 9 years deep, the most recent figure standing at -$12.2 million for Q1 2026.

• In Q1 2026, EBT fell 8.93% year-over-year to -$12.2 million; the TTM figure through Mar 2026 stood at -$40.2 million (down 713.57% YoY), while the FY2025 annual figure was -$39.2 million, down 6466.99% from the prior year.
• EBT was -$12.2 million for Q1 2026 at TELA Bio, down from -$9.5 million in the prior quarter.
• In the past five years, EBT ranged from a high of $29.2 million in Q4 2024 to a low of -$13.6 million in Q4 2023.
• Historically, EBT has averaged -$8.4 million across 5 years, with a median of -$10.8 million in 2022.
• The sharpest annual moves came in 2024 and 2025: EBT jumped 314.7% in 2024, then slumped 132.32% in 2025.
• A 5-year view of EBT shows it stood at -$10.6 million in 2022, then fell by 28.36% to -$13.6 million in 2023, then jumped by 314.7% to $29.2 million in 2024, then slumped by 132.32% to -$9.5 million in 2025, then retreated by 29.21% to -$12.2 million in 2026.
• The last three EBT figures came in at -$12.2 million (Q1 2026), -$9.5 million (Q4 2025), and -$8.6 million (Q3 2025), per Business Quant data.